The different aspects of obesity and its correlation to the Cardiometabolic and Renal risks
The link between the Heart, Diabetes and the Kidney
The Genetics of Cardio-Renal and Metabolic Disorders
Your knowledge about the Management of Obesity (Lifestyle Medical and surgical)
The roles of Technology in these domains
The role of Health Education in the Cardiometabolic and Renal domains
How to use risk scores for Diabetes, ASCVD, HF, and CKD
The knowledge about the management of diabetes and its related disorders like obesity, hypertension, dyslipidemia, and hyperglycemia
The SGLT2 inhibitors possible roles in optimizing the cardiovascular outcome in patients with or without diabetes
The roles of GLP1 Receptor agonists in the management of diabetes, obesity, and the prevention of ASCVD
The role of PCSK9 inhibitors in dyslipidemia and the possible cardiometabolic prevention
How to manage patients with CKD and/or Heart Failure with or without diabetes and the possible roles of the SGLT2 inhibitors
The possibility of modifying the existing clinical practice recommendations based on the latest evidence related in particular to the GLP1 Receptor agonists and the SGLT2 inhibitors
Who should Attend
Diabetologists
Physicians
Nephrologists
Cardiologists
Past Events
Heart, Diabetes and Kidney: Make The Link Wave II - 08-10 Dec 2023, Istanbul, Turkey [Postponed] (100698)
Important
Please, check "Heart, Diabetes and Kidney: Make The Link Wave II" official website for possible changes, before making any traveling arrangements
Event Categories
Health & Medicine: Cardiology, Diabetes, Nephrology